Financial Ratios Medical Ikkou Group Co.,Ltd.

Equities

3353

JP3921040006

Drug Retailers

Delayed Japan Exchange Other stock markets 10:39:28 2026-01-19 pm EST			5-day change	1st Jan Change
2,981.00 ^JPY	+1.02%		-3.53%	+1.74%

25-04-23	Medical Ikkou Group Co.,Ltd. cancelled the acquisition of Shizuoka Sawai Yakuhin K.K. from Shinichi Takeshita.	CI
25-04-04	Medical Ikkou Group - To Cancel Own Shares Representing 7.37% Issued Shares	RE

3843c28d921834f7ac577ab9c023e4.3VAS4papEVCoXxL0yAxYvb9uka936CxJRtD0Nx49Zmk.vwVoqKL-IjibEHiysjoq2Owjzpg_0X8xHKWnRVBtEgCkI1WH_O59PpwJdQ

Published financial data: MEDICAL IKKOU GROUP CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: February	2021	2022	2023	2024	2025
Revenues	31.6B	33.6B	33.9B	39.9B	48.39B
Total Revenues	31.6B	33.6B	33.9B	39.9B	48.39B
Cost of Goods Sold, Total	28.4B	29.98B	30.72B	35.35B	42.65B
Gross Profit	3.2B	3.61B	3.18B	4.55B	5.74B
Selling General & Admin Expenses, Total	1.71B	1.76B	1.71B	2.54B	3.62B
Provision for Bad Debts	-	-	-	-	4M
Amortization of Goodwill and Intangible Assets - (IS)	209M	242M	209M	171M	138M
Other Operating Expenses	251M	331M	325M	277M	290M
Other Operating Expenses, Total	2.17B	2.34B	2.25B	2.99B	4.05B
Operating Income	1.03B	1.28B	935M	1.56B	1.69B
Interest Expense, Total	-53M	-58M	-50M	-54M	-63M
Interest And Investment Income	27M	30M	39M	47M	72M
Net Interest Expenses	-26M	-28M	-11M	-7M	9M
Other Non Operating Income (Expenses)	199M	110M	301M	198M	114M
EBT, Excl. Unusual Items	1.2B	1.36B	1.22B	1.75B	1.82B
Gain (Loss) On Sale Of Investments	322M	106M	36M	167M	117M
Gain (Loss) On Sale Of Assets	2M	28M	20M	-2M	77M
Asset Writedown	-80M	-10M	-36M	-256M	-208M
Other Unusual Items	-4M	-5M	67M	2M	99M
EBT, Incl. Unusual Items	1.44B	1.48B	1.31B	1.66B	1.9B
Income Tax Expense	607M	607M	540M	581M	754M
Earnings From Continuing Operations	836M	869M	772M	1.08B	1.15B
Net Income to Company	836M	869M	772M	1.08B	1.15B
Minority Interest	-	-17M	-13M	-41M	-13M
Net Income - (IS)	836M	852M	759M	1.04B	1.13B
Net Income to Common Incl Extra Items	836M	852M	759M	1.04B	1.13B
Net Income to Common Excl. Extra Items	836M	852M	759M	1.04B	1.13B
Per Share Items
Net EPS - Basic	221.58	226.83	202.04	276.5	301.31
Basic EPS - Continuing Operations	221.58	226.83	202.04	276.5	301.31
Basic Weighted Average Shares Outstanding	3.77M	3.76M	3.76M	3.76M	3.76M
Net EPS - Diluted	221.58	226.83	202.04	276.5	301.31
Diluted EPS - Continuing Operations	221.58	226.83	202.04	276.5	301.31
Diluted Weighted Average Shares Outstanding	3.77M	3.76M	3.76M	3.76M	3.76M
Normalized Basic EPS	199.28	221.28	200.35	280.16	298.22
Normalized Diluted EPS	199.28	221.28	200.35	280.16	298.22
Dividend Per Share	80	40	40	45	60
Payout Ratio	19.14	17.61	19.76	14.44	16.5
Supplemental Items
EBITDA	1.86B	2.14B	1.78B	2.34B	2.45B
EBITA	1.24B	1.52B	1.14B	1.73B	1.83B
EBIT	1.03B	1.28B	935M	1.56B	1.69B
Effective Tax Rate - (Ratio)	42.07	41.12	41.16	34.98	39.68
Normalized Net Income	752M	831M	753M	1.05B	1.12B
Non-Cash Pension Expense	-1.95M	9.61M	22.1M	6.81M	50.15M
Supplemental Operating Expense Items
General and Administrative Expenses	237M	268M	246M	275M	352M

Fiscal Period: February	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7B	7.99B	6.44B	7.7B	6.77B
Total Cash And Short Term Investments	7B	7.99B	6.44B	7.7B	6.77B
Accounts Receivable, Total	4.74B	4.89B	5.01B	6.06B	7.48B
Total Receivables	4.74B	4.89B	5.01B	6.06B	7.48B
Inventory	1.1B	1.21B	1.23B	1.75B	2.22B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	821M	483M	561M	1.21B	1.5B
Total Current Assets	13.65B	14.58B	13.24B	16.72B	17.96B
Net Property Plant And Equipment	10.11B	9.86B	9.59B	9.12B	10.04B
Long-term Investments	2.43B	2.52B	2.84B	4.5B	4.71B
Goodwill	1.78B	1.54B	1.3B	692M	816M
Other Intangibles, Total	153M	177M	182M	168M	173M
Deferred Tax Assets Long-Term	422M	419M	363M	464M	521M
Other Long-Term Assets, Total	2M	2M	2M	2M	-
Total Assets	28.56B	29.09B	27.5B	31.66B	34.23B
Liabilities
Accounts Payable, Total	3.49B	3.48B	3.44B	5.23B	6.07B
Accrued Expenses, Total	221M	226M	222M	276M	266M
Short-term Borrowings	740M	170M	170M	1.34B	1.18B
Current Portion of Long-Term Debt	3.25B	3.56B	2.69B	2.35B	2.61B
Current Income Taxes Payable	359M	279M	189M	380M	535M
Other Current Liabilities	1.04B	698M	741M	823M	1.01B
Total Current Liabilities	9.1B	8.42B	7.45B	10.4B	11.67B
Long-Term Debt	7.61B	7.37B	6.06B	5.72B	6.05B
Long-Term Leases	245M	207M	189M	166M	175M
Pension & Other Post Retirement Benefits	696M	761M	802M	1.02B	1.1B
Other Non Current Liabilities	420M	411M	392M	516M	525M
Total Liabilities	18.07B	17.17B	14.9B	17.82B	19.52B
Common Stock, Total	917M	917M	917M	917M	917M
Additional Paid In Capital	853M	1.08B	1.08B	1.08B	1.08B
Retained Earnings	9.25B	9.95B	10.56B	11.45B	12.39B
Treasury Stock	-541M	-541M	-539M	-537M	-531M
Comprehensive Income and Other	9M	-21M	32M	332M	235M
Total Common Equity	10.48B	11.38B	12.05B	13.24B	14.1B
Minority Interest	-	544M	558M	600M	614M
Total Equity	10.48B	11.93B	12.61B	13.84B	14.71B
Total Liabilities And Equity	28.56B	29.09B	27.5B	31.66B	34.23B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.76M	3.76M	3.76M	3.76M	3.76M
ECS Total Common Shares Outstanding	3.76M	3.76M	3.76M	3.76M	3.76M
Book Value / Share	2.79K	3.03K	3.21K	3.52K	3.75K
Tangible Book Value	8.55B	9.67B	10.57B	12.38B	13.11B
Tangible Book Value Per Share	2.28K	2.57K	2.81K	3.29K	3.48K
Total Debt	11.85B	11.31B	9.12B	9.58B	10.02B
Net Debt	4.84B	3.32B	2.67B	1.88B	3.25B
Debt Equivalent of Unfunded Proj. Benefit Obligation	696M	761M	802M	927M	1B
Minority Interest, Total (Incl. Fin. Div)	-	544M	558M	600M	614M
Equity Method Investments, Total	-	-	-	10M	-
Inventories - Finished Goods, Total	1.1B	1.21B	1.23B	1.75B	2.22B
Full Time Employees	1.3K	1.32K	1.3K	1.43K	1.55K
Accumulated Allowance for Doubtful Accounts (Supple)	2M	2M	2M	2M	6M

Fiscal Period: February	2021	2022	2023	2024	2025
Net Income	1.44B	1.48B	1.31B	1.66B	1.9B
Depreciation & Amortization - CF	626M	628M	632M	612M	624M
Amortization of Goodwill and Intangible Assets - (CF)	209M	242M	209M	171M	138M
Depreciation & Amortization, Total	835M	870M	841M	783M	762M
(Gain) Loss From Sale Of Asset	79M	-17M	15M	236M	127M
(Gain) Loss on Sale of Investments - (CF)	-321M	-115M	-35M	-172M	-117M
Other Operating Activities, Total	-606M	-730M	-568M	-494M	-676M
Change In Accounts Receivable	86M	-153M	-118M	928M	-401M
Change In Inventories	49M	-119M	-14M	-60M	-127M
Change In Accounts Payable	95M	-69M	-44M	1.8B	-319M
Change in Other Net Operating Assets	162M	-8M	-83M	-405M	48M
Cash from Operations	1.82B	1.14B	1.31B	4.28B	1.2B
Capital Expenditure	-470M	-322M	-311M	-302M	-996M
Sale of Property, Plant, and Equipment	8M	2M	20M	14M	7M
Cash Acquisitions	-665M	-	-	28M	545M
Divestitures	-	-	-	553M	-
Sale (Purchase) of Intangible assets	-17M	-14M	-35M	-21M	-38M
Investment in Marketable and Equity Securities, Total	17M	50M	-100M	-193M	-277M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-500M
Other Investing Activities, Total	-53M	69M	-51M	-3.3B	125M
Cash from Investing	-1.18B	-215M	-477M	-3.22B	-1.13B
Short Term Debt Issued, Total	497M	-	-	1.15B	-
Long-Term Debt Issued, Total	3.97B	3.7B	1.45B	2.15B	2.4B
Total Debt Issued	4.47B	3.7B	1.45B	3.3B	2.4B
Short Term Debt Repaid, Total	-	-570M	-	-	-397M
Long-Term Debt Repaid, Total	-3.4B	-3.63B	-3.63B	-2.84B	-2.82B
Total Debt Repaid	-3.4B	-4.2B	-3.63B	-2.84B	-3.21B
Repurchase of Common Stock	-271M	-	-	-	-
Common Dividends Paid	-160M	-150M	-150M	-150M	-187M
Common & Preferred Stock Dividends Paid	-160M	-150M	-150M	-150M	-187M
Other Financing Activities, Total	-44M	712M	-39M	-33M	-28M
Cash from Financing	590M	64M	-2.37B	277M	-1.03B
Miscellaneous Cash Flow Adjustments	-	-	-	-	13M
Net Change in Cash	1.23B	984M	-1.54B	1.34B	-950M
Supplemental Items
Cash Interest Paid	53M	59M	50M	54M	65M
Cash Income Tax Paid (Refund)	607M	725M	567M	493M	673M
Levered Free Cash Flow	1.04B	938M	743M	1.29B	-260M
Unlevered Free Cash Flow	1.07B	974M	774M	1.33B	-220M
Change In Net Working Capital	-80M	357M	305M	106M	1.01B
Net Debt Issued / Repaid	1.06B	-498M	-2.18B	460M	-812M

Fiscal Period: February	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.35	2.76	2.06	3.29	3.21
Return on Total Capital	3.02	3.5	2.6	4.32	4.39
Return On Equity %	8.09	7.75	6.29	8.17	8.03
Return on Common Equity	8.09	7.79	6.48	8.22	8.29
Margin Analysis
Gross Profit Margin %	10.13	10.75	9.39	11.41	11.87
SG&A Margin	5.42	5.25	5.05	6.38	7.48
EBITDA Margin %	5.9	6.38	5.24	5.87	5.07
EBITA Margin %	3.92	4.52	3.37	4.34	3.78
EBIT Margin %	3.26	3.8	2.76	3.91	3.5
Income From Continuing Operations Margin %	2.65	2.59	2.28	2.71	2.37
Net Income Margin %	2.65	2.54	2.24	2.6	2.34
Net Avail. For Common Margin %	2.65	2.54	2.24	2.6	2.34
Normalized Net Income Margin	2.38	2.47	2.22	2.64	2.32
Levered Free Cash Flow Margin	3.29	2.79	2.19	3.24	-0.54
Unlevered Free Cash Flow Margin	3.39	2.9	2.28	3.33	-0.46
Asset Turnover
Asset Turnover	1.15	1.17	1.2	1.35	1.47
Fixed Assets Turnover	3.14	3.36	3.49	4.27	5.05
Receivables Turnover (Average Receivables)	6.73	6.98	6.85	7.21	7.15
Inventory Turnover (Average Inventory)	25.4	25.97	25.16	23.72	21.5
Short Term Liquidity
Current Ratio	1.5	1.73	1.78	1.61	1.54
Quick Ratio	1.29	1.53	1.54	1.32	1.22
Operating Cash Flow to Current Liabilities	0.2	0.13	0.18	0.41	0.1
Days Sales Outstanding (Average Receivables)	54.24	52.28	53.27	50.75	51.05
Days Outstanding Inventory (Average Inventory)	14.37	14.05	14.51	15.43	16.98
Average Days Payable Outstanding	44.17	42.27	41.09	44.22	47.85
Cash Conversion Cycle (Average Days)	24.44	24.06	26.69	21.95	20.18
Long Term Solvency
Total Debt/Equity	112.99	94.84	72.31	69.2	68.09
Total Debt / Total Capital	53.05	48.67	41.96	40.9	40.51
LT Debt/Equity	74.93	63.54	49.59	42.51	42.33
Long-Term Debt / Total Capital	35.18	32.61	28.78	25.12	25.18
Total Liabilities / Total Assets	63.28	59.01	54.17	56.28	57.02
EBIT / Interest Expense	19.43	21.98	18.7	28.87	26.86
EBITDA / Interest Expense	35.19	36.98	35.52	43.37	38.95
(EBITDA - Capex) / Interest Expense	26.32	31.43	29.3	37.78	23.14
Total Debt / EBITDA	6.35	5.27	5.13	4.09	4.08
Net Debt / EBITDA	2.6	1.55	1.5	0.8	1.32
Total Debt / (EBITDA - Capex)	8.49	6.2	6.22	4.69	6.87
Net Debt / (EBITDA - Capex)	3.47	1.82	1.82	0.92	2.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-1.37	6.3	0.9	17.71	21.29
Gross Profit, 1 Yr. Growth %	-6.89	12.84	-11.93	43.02	26.21
EBITDA, 1 Yr. Growth %	-8.13	15.01	-17.2	31.87	4.78
EBITA, 1 Yr. Growth %	-11.25	22.44	-24.59	51.22	5.78
EBIT, 1 Yr. Growth %	-14.52	23.79	-26.67	66.74	8.53
Earnings From Cont. Operations, 1 Yr. Growth %	4.37	3.95	-11.16	39.9	6.11
Net Income, 1 Yr. Growth %	4.37	1.91	-10.92	36.89	9.05
Normalized Net Income, 1 Yr. Growth %	-1.72	10.54	-9.45	39.88	6.52
Diluted EPS Before Extra, 1 Yr. Growth %	5.46	2.37	-10.93	36.85	8.97
Accounts Receivable, 1 Yr. Growth %	1.67	3.23	2.43	20.99	23.46
Inventory, 1 Yr. Growth %	-4.03	10.87	1.15	42.67	26.43
Net Property, Plant and Equip., 1 Yr. Growth %	1.28	-2.47	-2.81	-4.91	10.16
Total Assets, 1 Yr. Growth %	9.02	1.89	-5.46	15.1	8.12
Tangible Book Value, 1 Yr. Growth %	-2.79	13.07	9.31	17.12	5.88
Common Equity, 1 Yr. Growth %	3.1	8.56	5.84	9.89	6.47
Cash From Operations, 1 Yr. Growth %	-0.05	-37.71	15.15	227.24	-71.99
Capital Expenditures, 1 Yr. Growth %	4.21	-31.49	-3.42	-2.89	229.8
Levered Free Cash Flow, 1 Yr. Growth %	-26.28	-9.72	-20.74	74.21	-120.07
Unlevered Free Cash Flow, 1 Yr. Growth %	-25.84	-9.13	-20.49	71.54	-116.6
Dividend Per Share, 1 Yr. Growth %	100	-50	0	12.5	33.33
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.61	2.39	3.57	8.98	19.48
Gross Profit, 2 Yr. CAGR %	-0.97	2.5	-0.31	12.23	34.36
EBITDA, 2 Yr. CAGR %	-0.72	2.79	-2.42	4.49	17.55
EBITA, 2 Yr. CAGR %	0.16	4.24	-3.91	6.79	26.48
EBIT, 2 Yr. CAGR %	-0.67	2.86	-4.72	10.58	34.52
Earnings From Cont. Operations, 2 Yr. CAGR %	8.43	4.16	-3.9	11.48	21.84
Net Income, 2 Yr. CAGR %	8.43	3.13	-4.72	10.43	22.18
Normalized Net Income, 2 Yr. CAGR %	6.94	4.23	0.05	12.55	22.06
Diluted EPS Before Extra, 2 Yr. CAGR %	9.21	3.9	-4.51	10.41	22.12
Accounts Receivable, 2 Yr. CAGR %	1.72	2.45	2.83	11.33	22.22
Inventory, 2 Yr. CAGR %	2.36	3.15	5.9	20.13	34.3
Net Property, Plant and Equip., 2 Yr. CAGR %	-1.38	-0.61	-2.64	-3.87	2.35
Total Assets, 2 Yr. CAGR %	4.37	5.39	-1.86	4.32	11.56
Tangible Book Value, 2 Yr. CAGR %	3.52	4.84	11.17	13.15	11.36
Common Equity, 2 Yr. CAGR %	4.78	5.8	7.19	7.85	8.17
Cash From Operations, 2 Yr. CAGR %	87.91	-21.1	-15.3	94.12	-4.26
Capital Expenditures, 2 Yr. CAGR %	-34.15	-15.5	-18.65	-3.16	78.96
Levered Free Cash Flow, 2 Yr. CAGR %	25.2	-18.42	-15.41	17.51	-40.86
Unlevered Free Cash Flow, 2 Yr. CAGR %	31	-17.91	-15	16.79	-46.64
Dividend Per Share, 2 Yr. CAGR %	41.42	0	-29.29	6.07	22.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.74	2.47	1.89	8.08	12.94
Gross Profit, 3 Yr. CAGR %	-2.9	3.43	-2.56	12.43	16.71
EBITDA, 3 Yr. CAGR %	-5.24	4.27	-4.36	7.89	4.59
EBITA, 3 Yr. CAGR %	-7.39	7.1	-6.42	11.77	6.45
EBIT, 3 Yr. CAGR %	-9.85	6.89	-8.11	14.82	9.89
Earnings From Cont. Operations, 3 Yr. CAGR %	-12.27	6.92	-1.22	8.91	9.66
Net Income, 3 Yr. CAGR %	-12.27	6.22	-1.78	7.52	9.97
Normalized Net Income, 3 Yr. CAGR %	-4.56	8.12	-0.54	11.87	10.5
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.81	6.88	-1.3	7.66	9.93
Accounts Receivable, 3 Yr. CAGR %	3.8	2.22	2.44	8.56	15.23
Inventory, 3 Yr. CAGR %	-1.13	5.12	2.48	16.96	22.19
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.01	-1.75	-1.35	-3.4	0.6
Total Assets, 3 Yr. CAGR %	3.54	3.54	1.64	3.5	5.57
Tangible Book Value, 3 Yr. CAGR %	1.52	6.61	6.31	13.12	10.67
Common Equity, 3 Yr. CAGR %	4.08	6.02	5.81	8.09	7.39
Cash From Operations, 3 Yr. CAGR %	8.51	30.05	-10.5	32.9	1.82
Capital Expenditures, 3 Yr. CAGR %	3.74	-33.28	-11.65	-13.71	45.7
Levered Free Cash Flow, 3 Yr. CAGR %	2.84	12.27	-19.2	7.62	-34.8
Unlevered Free Cash Flow, 3 Yr. CAGR %	2.38	15.96	-18.78	7.42	-39.05
Dividend Per Share, 3 Yr. CAGR %	25.99	0	0	-17.45	14.47
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.52	2.64	1.86	5.03	8.6
Gross Profit, 5 Yr. CAGR %	0	2.02	-1.88	6.87	10.8
EBITDA, 5 Yr. CAGR %	-2.89	1.83	-4.12	4.36	3.87
EBITA, 5 Yr. CAGR %	-4.4	2.47	-6.01	6.97	5.56
EBIT, 5 Yr. CAGR %	-6.3	1.22	-7.84	8.35	7.02
Earnings From Cont. Operations, 5 Yr. CAGR %	-1.68	-1.89	-9.01	8.72	7.43
Net Income, 5 Yr. CAGR %	-1.68	-2.28	-9.32	7.88	7.18
Normalized Net Income, 5 Yr. CAGR %	-3.56	2.89	-2.74	9.87	7.95
Diluted EPS Before Extra, 5 Yr. CAGR %	-1.38	-1.88	-8.96	8.28	7.48
Accounts Receivable, 5 Yr. CAGR %	4.83	6.18	3.41	5.77	9.94
Inventory, 5 Yr. CAGR %	0.98	1.99	1.62	10.89	14.19
Net Property, Plant and Equip., 5 Yr. CAGR %	1.21	-0.41	-1.07	-2.6	0.11
Total Assets, 5 Yr. CAGR %	2.86	3.16	1.35	3.85	5.5
Tangible Book Value, 5 Yr. CAGR %	7.06	7.54	5.28	9.18	8.3
Common Equity, 5 Yr. CAGR %	7.66	7.06	5.31	6.75	6.75
Cash From Operations, 5 Yr. CAGR %	3.22	11.49	-1.73	52.65	-8.05
Capital Expenditures, 5 Yr. CAGR %	-10.42	-3.96	-5.88	-22.55	17.17
Levered Free Cash Flow, 5 Yr. CAGR %	8.87	30.25	-4.89	14.33	-28.69
Unlevered Free Cash Flow, 5 Yr. CAGR %	7.77	26.39	-4.96	16.29	-31.34
Dividend Per Share, 5 Yr. CAGR %	18.49	1.03	0	2.38	8.45